From July 1, 2023 to August 14, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on August 15, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.77 USD | -2.75% |
|
+18.00% | +1.14% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.14% | 10.1M | |
+22.15% | 46.56B | |
+44.76% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
+20.42% | 28.18B | |
-6.35% | 28.1B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- PSTV Stock
- News Plus Therapeutics, Inc.
- Tranche Update on Plus Therapeutics, Inc.'s Equity Buyback Plan announced on August 15, 2022.